Femasys Stock Beneish M Score

FEMY Stock  USD 1.55  0.08  5.44%   
This module uses fundamental data of Femasys to approximate the value of its Beneish M Score. Femasys M Score tells investors if the company management is likely to be manipulating earnings. The score is calculated using eight financial indicators that are adjusted by a specific multiplier. Please note, the M Score is a probabilistic model and cannot detect companies that manipulate their earnings with 100% accuracy. Check out Femasys Piotroski F Score and Femasys Altman Z Score analysis.
For more information on how to buy Femasys Stock please use our How to Invest in Femasys guide.
  
At this time, Femasys' Short Term Debt is fairly stable compared to the past year. Short and Long Term Debt is likely to rise to about 266 K in 2024, whereas Short and Long Term Debt Total is likely to drop slightly above 464.9 K in 2024. At this time, Femasys' Price To Book Ratio is fairly stable compared to the past year.
At this time, it appears that Femasys is an unlikely manipulator. The earnings manipulation may begin if Femasys' top management creates an artificial sense of financial success, forcing the stock price to be traded at a high price-earnings multiple than it should be. In general, excessive earnings management by Femasys executives may lead to removing some of the operating profits from subsequent periods to inflate earnings in the following periods. This way, the manipulation of Femasys' earnings can lead to misrepresentations of actual financial condition, taking the otherwise loyal stakeholders on to the path of questionable ethical practices and plain fraud.
-2.83
Beneish M Score - Unlikely Manipulator
Elasticity of Receivables

0.97

Focus
Asset Quality

1.16

Focus
Expense Coverage

0.66

Focus
Gross Margin Strengs

1.05

Focus
Accruals Factor

0.66

Focus
Depreciation Resistance

0.99

Focus
Net Sales Growth

1.1

Focus
Financial Leverage Condition

1.12

Focus

Femasys Beneish M-Score Indicator Trends

The cure to earnings manipulation is the transparency of financial reporting. It will typically remove the temptation of the top executives to inflate earnings (i.e., to promote the idea of 'winning at any cost'). Because a healthy internal audit department can enhance transparency, the board should promote the auditors' access to all the record-keeping systems across the enterprise. For example, if Femasys' auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back.
Current ValueLast YearChange From Last Year 10 Year Trend
Net Receivables74.2 K69.7 K
Notably Up
Very volatile
Total Revenue1.2 M1.1 M
Significantly Up
Slightly volatile
Total Assets18.1 M19.4 M
Significantly Down
Slightly volatile
Total Current Assets14.2 M16.3 M
Fairly Down
Slightly volatile
Non Current Assets Total2.8 M2.5 M
Moderately Up
Slightly volatile
Property Plant Equipment2.2 M1.6 M
Significantly Up
Slightly volatile
Depreciation And Amortization961.3 K708.4 K
Significantly Up
Slightly volatile
Selling General Administrative4.9 M6.8 M
Way Down
Slightly volatile
Total Current Liabilities1.5 M1.4 M
Significantly Up
Slightly volatile
Non Current Liabilities Total107.1 K112.7 K
Notably Down
Slightly volatile
Short Term Debt526.9 K463.6 K
Fairly Up
Slightly volatile
Long Term Debt146 K164.2 K
Fairly Down
Slightly volatile
Gross Profit Margin0.770.73
Notably Up
Slightly volatile

Femasys Beneish M-Score Driver Matrix

One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to detect the potential manipulation of earnings. Understanding the correlation between Femasys' different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Femasys in a much-optimized way. Analyzing correlations between earnings drivers directly associated with dollar figures is the most effective way to find Femasys' degree of accounting gimmicks and manipulations.

About Femasys Beneish M Score

M-Score is one of many grading techniques for value stocks. It was developed by Professor M. Daniel Beneish of the Kelley School of Business at Indiana University and published in 1999 under the paper titled The Detection of Earnings Manipulation. The Beneish score is a multi-factor model that utilizes financial identifiers to compile eight variables used to classify whether a company has manipulated its reported earnings. The variables are built from the officially filed financial statements to create a final score call 'M Score.' The score helps to identify companies that are likely to manipulate their profits if they show deteriorating gross margins, operating expenses, and leverage against growing revenue.

Depreciation And Amortization

961,290

At this time, Femasys' Depreciation And Amortization is fairly stable compared to the past year.

About Femasys Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Femasys's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Femasys using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Femasys based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Femasys Inc., a biomedical company, focuses on womens healthcare market in the United States. Femasys Inc. was incorporated in 2004 and is based in Suwanee, Georgia. Femasys operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 27 people.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Femasys offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Femasys' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Femasys Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Femasys Stock:
Check out Femasys Piotroski F Score and Femasys Altman Z Score analysis.
For more information on how to buy Femasys Stock please use our How to Invest in Femasys guide.
You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Complementary Tools for Femasys Stock analysis

When running Femasys' price analysis, check to measure Femasys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Femasys is operating at the current time. Most of Femasys' value examination focuses on studying past and present price action to predict the probability of Femasys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Femasys' price. Additionally, you may evaluate how the addition of Femasys to your portfolios can decrease your overall portfolio volatility.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Is Femasys' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Femasys. If investors know Femasys will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Femasys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.98)
Revenue Per Share
0.084
Quarterly Revenue Growth
(0.30)
Return On Assets
(0.47)
Return On Equity
(0.90)
The market value of Femasys is measured differently than its book value, which is the value of Femasys that is recorded on the company's balance sheet. Investors also form their own opinion of Femasys' value that differs from its market value or its book value, called intrinsic value, which is Femasys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Femasys' market value can be influenced by many factors that don't directly affect Femasys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Femasys' value and its price as these two are different measures arrived at by different means. Investors typically determine if Femasys is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Femasys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.